Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian ...

Pancreatic ductal adenocarcinoma is one of the deadliest cancer types, with a five-year survival rate of 13%. There are only ...

Every participant in a new bowel cancer immunotherapy trial remained cancer-free nearly three years after receiving ...

Health minister hopes a key injectable cancer drug will be available in all five trusts "as soon as possible".

An innovative treatment for bladder cancer successfully prevented the recurrence of tumors and improved survival rates following surgery.

There is a classic image in cancer treatment of a patient triumphantly ringing a bell to commemorate the end of chemotherapy ...

New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other ...

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...

The monarch has spent the afternoon speaking with healthcare professionals and chemotherapy patients before unveiling a ...

But their options are expanding like never before as a wave of new research and therapies are “moving beyond a ‘one-size-fits ...